Feb 6 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2022 Dec 31, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 554 mln 448 mln 775 mln
(+23.8 pct) (+8.1 pct) (+19.7 pct)
Operating 18 mln loss 136 mln 3 mln
Recurring loss 67 mln loss 232 mln loss 95 mln
Net loss 76 mln loss 243 mln loss 120 mln
EPS loss 8.20 yen loss 26.14 yen loss 12.88 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T